Select Medical
SEM was delisted on the 30th of June, 2026.
155 hedge funds and large institutions have $1.62B invested in Select Medical in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 55 reducing their positions, and 23 closing their positions.
13% more capital invested
Capital invested by funds: $1.44B → $1.62B (+$189M)
7% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 55
2.44% less ownership
Funds ownership: 150.37% → 147.93% (-2.4%)
5% less funds holding
Funds holding: 164 → 155 (-9)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$22.3M |
| 2 |
Millennium Management
New York
|
+$14.4M |
| 3 |
DM
Deerfield Management
New York
|
+$7.03M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.14M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$5.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
-$30.1M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$13.3M |
| 3 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$9.75M |
| 4 |
SAM
Senzar Asset Management
New York
|
-$8.84M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$5.12M |
SEM Hedge Fund Activity: Q2 2017 in Review
155 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2017, worth a combined $1.62B — up 13% from $1.44B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of SEM and 14 opened new positions — a net loss of 9 holders — while 55 trimmed existing stakes and 51 added.
The largest buyer was OrbiMed, adding an estimated $22.3M. The largest seller was LSV Asset Management, exiting entirely with an estimated $30.1M sold.
- 155 institutional investors held Select Medical (SEM) as of Q2 2017, down from 164 in Q1 2017.
- Funds reported $1.62B of Select Medical stock for Q2 2017, up 13% quarter-over-quarter.
- 14 funds opened new Select Medical positions in Q2 2017 and 23 closed out, a net change of -9 holders.
- The largest Select Medical buyer in Q2 2017 was OrbiMed, an estimated $22.3M added.
- The largest Select Medical seller in Q2 2017 was LSV Asset Management, an estimated $30.1M sold.
Based on aggregated 13F filings for Q2 2017.